Prognostic parameters other than Gleason score for the daily evaluation of prostate cancer in needle biopsy

Eur Urol. 2005 Oct;48(4):566-71. doi: 10.1016/j.eururo.2005.06.016.

Abstract

Objective: To evaluate in prostate needle biopsies the usefulness and the efficacy of not time-consuming morphologic parameters in order to predict whether prostate cancer is organ-confined or it is not, that could contribute additional information to pre-surgical serum PSA and Gleason score, both of them parameters already accepted as clinically significant.

Methods: Three hundred and two consecutive patients were evaluated, of whom a diagnostic needle biopsy and the radical prostatectomy specimen with no pre-surgical hormone therapy were available. Bilateral or unilateral extension, number of positive cores, percentage of positive cores, intraprostatic perineural invasion (IPNI) and the presence of high-grade prostatic intraepithelial neoplasia (HGPIN) in any of the biopsy cores were evaluated in the needle biopsy.

Results: The median of cores is 6. The IPNI, the presence of bilateral tumour, and the percentage of positive cores, higher than 37.5% (ROC curve), show significant crude OR (4.0, 2.8, 6.9 respectively). The regression model discloses that only the percentage of positive cores shows a significant OR (5.8) adjusting for bilaterality, IPNI, HGPIN and age.

Conclusions: The percentage of cores with cancer and the bilateral involvement are another two parameters predictive of cancer with extraprostatic extension. (p<0.0005 in both). IPNI has statistical significance too (p<0.002), but it is related to the tumour volume expressed through the two mentioned parameters.

Publication types

  • Evaluation Study

MeSH terms

  • Adult
  • Aged
  • Biomarkers, Tumor / blood
  • Biopsy, Fine-Needle
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Invasiveness
  • Neoplasm Staging
  • Predictive Value of Tests
  • Prognosis
  • Prostate-Specific Antigen / blood
  • Prostatic Intraepithelial Neoplasia / immunology
  • Prostatic Intraepithelial Neoplasia / pathology*
  • Prostatic Neoplasms / immunology
  • Prostatic Neoplasms / pathology*
  • Sensitivity and Specificity
  • Tumor Burden

Substances

  • Biomarkers, Tumor
  • Prostate-Specific Antigen